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ABSTRACT
Introduction With a view to inform policy for improved 
postabortion care, we describe abortion- related near- 
miss and mortality by sociodemographic risk factors and 
management options by pregnancy trimester in Uganda.
Methods This secondary data analysis used an adapted 
WHO near- miss methodology to collect cross- sectional 
maternal near- miss and abortion complications data at 43 
health facilities in Central and Eastern Uganda in 2016–
2017. We computed abortion severe morbidity, near- miss 
and mortality ratios per 100 000 live births, and described 
the proportion of cases that worsened to an abortion 
near- miss or death, stratified by geographical region and 
trimester. We tested for association between independent 
variables and abortion near- miss, and obtained prevalence 
ratios for association between second trimester near- 
miss and independent demographic and management 
indicators. We assessed health facility readiness for 
postabortion care provision in Central and Eastern regions.
Results Of 3315 recorded severe abortion morbidity 
cases, 1507 were near- misses. Severe abortion morbidity, 
near- miss and mortality ratios were 2063, 938 and 23 per 
100 000 live births, respectively. Abortion- related mortality 
ratios were 11 and 57 per 100 000 in Central and Eastern 
regions, respectively. Abortion near- miss cases were 
significantly associated with referral (p<0.001). Second 
trimester had greater abortion mortality than first trimester. 
Eastern region had greater abortion- related morbidity and 
mortality than Central region with facilities in the former 
characterised by inferior readiness to provide postabortion 
care.
Conclusions Uganda has a major abortion near- miss 
morbidity and mortality; with mortality higher in the second 
trimester. Life- saving commodities are lacking especially 
in Eastern region compromising facility readiness for 
postabortion care provision.
INTRODUCTION
Unsafe abortion is a major reproductive 
health challenge contributing to 7.9% global 
and 9.6% regional maternal deaths.1 2 Over 
75% of all abortions in sub- Saharan Africa, 
Uganda inclusive, are unsafe due to restrictive 
abortion laws.3 4 Furthermore, low socio-
economic status, low literacy rates and low 
contraceptive uptake are associated with high 
unsafe abortion rates and severe abortion 
morbidity (SAM).5–8 Abortion- related deaths 
are largely preventable if patients receive 
timely appropriate care such as postabortion 
care (PAC).9 10 PAC is essential life- saving care 
to address the impact of abortion- related 
Key questions
What is already known?
 ► The WHO near- miss indicator is proposed to assess 
the quality of maternal services and several stud-
ies provide evidence on the usefulness of the con-
cept using the original and adapted WHO near- miss 
approaches.
 ► A systematic review of 70 studies from 28 countries 
published in 2018 estimates an abortion near- miss 
rate of 9%, and a mortality rate of 1.5% among 
abortion- related hospital admissions.
What are the new findings?
 ► This is the first study to provide detailed characteri-
sation of abortion near- miss by pregnancy trimester.
 ► Using the adapted WHO near- miss criteria, we found 
a higher abortion- related mortality in the second 
compared with first trimester. Referred women were 
more likely to develop abortion near- miss. Women 
who had a near- miss abortion event in the second 
trimester had a lesser prevalence of uterine evacua-
tion or manual vacuum aspiration than spontaneous 
expulsion compared with women in the first trimes-
ter (crude prevalence ratio (cPR) 0.69, 95% CI 0.51 
to 0.93).
 ► The Eastern region of Uganda had less readiness 
for Post Abortion Care, with higher abortion- related 
morbidity and mortality. Although both results come 
from independent cross- sectional data and preclud-
ing causal inference, our result points to the impor-
tance of providing adequate services for women 
with abortion complications.
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complications which are primarily due to ‘unsafe’ abor-
tions.
Assessing the incidence of severe abortion and 
abortion- related mortality is important to gauge the 
quality and effectiveness of PAC. To standardise the 
assessments of morbidity, WHO defined a near- miss as 
‘a woman who nearly died but survived a complication 
that occurred during pregnancy, childbirth or within 42 
days of termination of pregnancy’.11 Abortion near- miss 
(ANM), a subset of maternal near- miss, may be the result 
of delays in accessing safe abortion care as well as delays 
in getting PAC when complications arise. While sponta-
neous and safe abortions are less likely to have near- miss 
complications (and deaths) than unsafe induced abor-
tions, PAC addresses both.12 Quality PAC is dependent on 
appropriate equipment, commodities, laboratory tests, 
guidelines and trained staff; this averts further harm and 
improves patient survival.
ANM is both a success and a failure with respect to 
quality of care. A success because the woman has been 
saved in extremis by hospital teams, especially if she 
arrived in a very severe condition at the facility. A failure, 
because she became so severely ill.13 Still, ANM occur-
rence and mortality is a valuable indicator for health 
systems’ planning, case management strategies and evalu-
ation of healthcare provided. Previous research proposed 
ANM incidences per 100 000 live births between 200 and 
450 and abortion- related mortality ratio (AMR) about 85 
per 100 000 live births in Africa.14–17
PAC was introduced in Uganda in the early 1990s as 
part of basic and comprehensive emergency obstetric 
care (EmOC) packages.18 19 PAC is offered by both 
midwives and doctors from primary level health facil-
ities and hospitals.20 Paul et al published research on 
barriers that women in Uganda face in accessing PAC 
services which lead to more severe complications.21 Little 
is known, however, if incidence and mortality differ in 
relation to PAC services by country region and to which 
extent complication rates are driven by sociodemo-
graphic status, reproductive characteristics or manage-
ment options by pregnancy trimester.17 Our study from 43 
facilities in two distinct regions of Uganda22 aims to assess 
abortion- related morbidity and mortality by region, and 
therewith differences in the availability of PAC services—
and by sociodemographic and reproductive characteris-
tics including trimester in Uganda.
METHODS
Study design, setting and participants
We collected cross- sectional data on maternal near- miss 
as part of a cluster randomised two- arm trial to assess the 
impact of a 1 day competency- based training ‘Helping 
Mothers Survive: Bleeding after Birth’ on morbidity 
and mortality due to postpartum haemorrhage (PPH). 
The primary trial details are reported elsewhere.23 The 
study was conducted in 11, and 7 districts in Central and 
Eastern regions of Uganda, respectively, at 22 hospitals, 
and 21 high case load health centres; 9 were private not 
for profit (PNFP) and 34 public. In each district, taken as 
a cluster, we included all public hospitals and randomly 
sampled health centres and PNFP health facilities with 
more than 400 deliveries per year. Ministry of Health 
Uganda recommended the selected districts and all 
health facilities offer at least basic EmOC services. Data 
collection run from June 2016 to September 2017.
Data collection
We used the WHO near- miss form to collect data of all 
maternal near- miss events, and deaths which took place 
in the selected health facilities.24 The data collection form 
was amended and included severe abortion complica-
tions, see online supplemental appendix I, as a screening 
question to ensure that these events were captured 
consistently. Details of categories for organ dysfunc-
tion, critical interventions, and other data collected are 
reported elsewhere.23
At each health facility, two of the midwives, selected 
as data collectors received a 1- day training on near- 
miss methodology and the data collection process. We 
collected data prospectively from several service points at 
the health facilities including (1) antenatal, labour and 
postnatal ward, (2) female and surgical ward, (3) labora-
tory and (4) theatre to ensure that all cases of near- miss 
and maternal deaths were included. A standard protocol 
was used to abstract information from the patient’s clin-
ical case notes and registries for admission, birth, theatre, 
laboratory and discharge. From the paper forms, the data 
collectors entered data onto a tablet- based application 
(Lenovo A3500- F) and uploaded onto the cloud server 
biweekly using Open Data Kit Collect software applica-
tion. Data on the total number of live births in the facili-
ties were collected through monthly telephone calls and 
verified during supervision visits. The data collectors 
were supported through biweekly supervision visits and 
regular telephone calls to ensure complete and correct 
abstraction of data.
This paper uses only the data on maternal near- misses 
admitted as abortion- related complications. An abortion 
was defined as termination of a pregnancy less than 28 
weeks gestation age. We extracted data for women coded 
as having abortion complications from those with severe 
maternal morbidity. Women with ectopic pregnancy or 
gestation age above 27 weeks were excluded, viability in 
Uganda begins at 28 weeks.19 Since PPH and abortion are 
both bleeding complications, we screened the PPH cases 
Key questions
What do the new findings imply?
 ► There is a major burden of abortion near- miss and mortality partic-
ularly in low- income settings.
 ► Women with second trimester abortion complications need urgent 
attention to avert severe abortion- related complications and deaths.
 ► Provision of essential drugs and supplies is crucial to averting 
abortion- related near- miss and deaths.
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to identify the abortion cases that were miscoded as PPH 
using a gestation age less than 28 weeks. Cases that were 
coded as abortion cases but where the gestation age was 
missing were not excluded from the data set (see online 
supplemental appendix II).
We assessed for PAC provision health facility readi-
ness at the 43 health facilities from February to April 
2016 using an adapted Uganda health facility assess-
ment tool. Components therein are very similar to the 
WHO service availability and readiness assessment tool,25 
however, we did not collect information on whether the 
abortion was spontaneous or induced, and provision of 
family planning services as these were not captured in the 
primary study tool. Key items measured that influence 
access and availability to PAC services at all the health 
facilities included: (1) uterotonics like misoprostol and 
oxytocin; (2) manual vacuum aspiration (MVA) sets; (3) 
intravenous fluids; (4) parenteral antibiotics; (5) ability 
to provide PAC services 24 hours a day, 7 days a week 
(24/7); (6) referral capability (motorised transport for 
referral, health provider accompanying a referral); (7) 
communication means; and for health facilities offering 
comprehensive EmOC; (8) blood transfusion services 
and (9) surgical/laparotomy capability.
Service readiness components like equipment and 
commodities were verified by checking their presence on 
the wards, pharmacy, laboratory and the health facility 
stores. Health facilities’ ability to provide PAC services 
24/7 was verified with checking duty schedules, ward and 
theatre registers for the previous 3 months. We inquired 
about the presence of motorised transport at the health 
facility, and whether the most recent referral to a higher 
facility had been accompanied by a health provider to 
check the referral capability.
Outcomes and explanatory variables
The main outcome, ANM, was defined using our adapted 
WHO near- miss criteria as a case of severe abortion 
complication with either organ dysfunction, severe sepsis, 
blood transfusion or laparotomy. Given the paucity of 
blood products in low to middle income countries, the 
threshold for massive blood transfusion was reduced 
to two units down from the five units recommended by 
WHO.14 26 27 Other outcomes were:
 ► SAM ratio (SAMR) as the number of all cases with 
severe abortion complications per 100 000 live births.
 ► ANMR as the number of abortion- related near- miss 
cases per 100 000 live births.
 ► AMR as the number of maternal deaths due to abor-
tion per 100 000 live births.
Independent variables included background char-
acteristics like gestation age based on weeks of amen-
orrhoea, patient’s age in completed years, number 
of pregnancies and timing of onset of complications. 
Reproductive and institutional factors like HIV status, 
referral status (referred into the facility), type of health 
facility and ownership. We also collected information on 
complications including infection, organ dysfunction 
and maternal death; as well as management options like 
types of uterine evacuation, uterotonics administered, 
and additional interventions, for example, blood trans-
fusion, number of blood transfusion units administered 
and laparotomy, all abstracted from the patient’s clinical 
case notes.
Statistical analysis
Statistical analysis was performed using Stata V.14. We 
present the number of women with severe abortion 
complications, ANM, abortion- related deaths; and SAMR, 
ANMR and AMR for all women in the study, then segre-
gated by region. We also present the proportions of SAM 
that had ANM or abortion- related deaths by region and 
pregnancy trimester. The estimates were not weighted 
for region. We designated health facility as a primary 
sampling unit and assigned all health facilities the same 
weight using STATA command svyset (pw=wgt), psu(id3) 
singleunit (centred).
Background characteristics and categorical outcomes 
were presented with descriptive statistics. Continuous 
variables were summarised using means (SD) or medians 
(IQR) and categorical variables using proportions (CIs). 
Pearson’s χ2 was used to test the difference between severe 
abortion complications cases and those that progressed 
to be ANM across different sociodemographic, reproduc-
tive and institutional characteristics. We computed 95% 
CIs and statistical significance established at p<0.05. We 
excluded women with missing data for gestation age and 
unrecorded HIV status in the statistical test computation 
for background and reproductive characteristics compar-
ison among near- miss cases to avoid misinterpretation of 
findings.
We then described the proportion of women with 
severe abortion complications or ANM that suffered 
complications such as infection, organ dysfunction, 
maternal death and the management options received 
including type of uterine evacuation, uterotonics admin-
istered, blood transfusion and when a laparotomy was 
performed. To examine the association between first and 
second trimester ANM and background characteristics, 
reproductive factors, institutional factors, types of compli-
cations and management options, we did multiple gener-
alised linear models with binomial family and log link to 
obtain unadjusted prevalence ratios effect estimates.
Regarding health facility readiness for PAC, we 
computed the percentage of facilities that fulfilled each 
readiness indicator, for all health facilities and for central 
and eastern region. Performed Pearson χ2 or Fischer’s 
exact tests to compare PAC health facility readiness 
between the central and eastern region.
Role of the funding source
The funder had no role in study conceptualisation, data 
collection, analysis and manuscript writing. All authors 
had full access to the study data and the corresponding 
author had final responsibility for the decision to submit 
for publication.
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RESULTS
We extracted data of 3315 (25.8%) SAM cases from the 
total of 12 843 severe maternal complications collected 
over a period of 15 months from 43 health facilities. Forty 
five percent (n=1507) of the 3315 women with severe 
abortion- related complications fulfilled the criteria 
as ANM cases (see online supplemental appendix II). 
During the same period, there were a total of 160 701 
live births at the study sites with the Central and Eastern 
regions having 118 674 and 42 027 live births, respectively.
The facility SAMR, ANMR and AMR were 2063, 938 
and 23 per 100 000 live births, respectively (see table 1). 
The Eastern region had an SAMR of 3641 and ANMR 
of 1785 per 100 000 live births; while the Central region 
had an SAMR of 1504 and ANMR of 638 per 100 000 live 
births. Thirty- seven women died from abortion compli-
cations with an AMR of 11 vs 57 per 100 000 live births 
in Central and Eastern region, respectively. Of the docu-
mented 1459 and 1044 first and second trimester severe 
abortion complications, 589 (40.4%) and 499 (47.8%), 
respectively, developed into an ANM and 5 (0.3%) and 
21 (2.0%), respectively, died.
In the Central region, out of 625 and 543 first and 
second trimester women with SAM, 284 (45.4%) and 
212 (39.0%), respectively, developed into ANM and 
1 (0.2%) and 6 (1.1%), respectively, died. While the 
Eastern region, had 36.6% and 57.3% of the SAM in the 
first and second trimester respectively develop ANM, and 
death occurred in 0.5% and 3.0% in the first and second 
trimester, respectively. The mean age of participants was 
26 years (SD 7), and the median number of pregnan-
cies was three (IQR 2–5) (see table 2). Patients referred 
into the health facilities were more likely to progress 
to develop an ANM (p<0.001). Regarding complica-
tions seen and management options in table 3, only 
243 women (16%) with ANM had an infection and 76% 
presented with organ dysfunction. Surgical uterine evac-
uation using MVA or curettage (D&C) was performed in 
58% of ANM cases, 41% had a spontaneous expulsion 
while only 1% got medical evacuation. Oxytocin was the 
commonly administered uterotonic in 58% of the cases, 
followed by misoprostol in 40%.
Only 42% of all ANM cases received a blood transfu-
sion, and 47% of patients who received blood transfu-
sion had their haemoglobin (Hb) checked at discharge. 
The median Hb at discharge was 72 g/L (IQR 58–90). 
Majority (58%) of the near- miss cases only got one unit of 
blood, 40% got 2–4 units of blood and 2% received five 
or more units.
Laparotomy was performed in 27 patients; nine and 11 of 
whom were in the first and second trimester, respectively, 
with gestation age not specified in seven patients (table 3). 
The indications for laparotomy included: uterine perfo-
ration in 10, 8 had pelvic abscess, 3 got subtotal hysterec-
tomy, 1 patient with missed abortion and disseminated 
intravascular coagulopathy had a hysterotomy, 2 patients 
with induced abortion had vesicovaginal fistula and 1 
of them in addition had a rectovaginal fistula. Majority 
(52%) of these laparotomies were performed between 3 
and 12 hours from admission. The prevalence of ANM 
complications developing after having been admitted at 
least 12 hours was 37% (cPR 1.37, 95% CI 1.07 to 1.76) 
higher in women with second trimester ANM compared 
with women with first trimester ANM (table 4). We also 
observed an association between second trimester ANM 
and the methods used for uterine evacuation. Women 
with second trimester ANM had a 31% (cPR 0.69, 95% CI 
0.51 to 0.93) lesser prevalence of uterine evacuation or 
MVA as opposed to a spontaneous expulsion compared 
with women with first trimester ANM.
All 43 health facilities could offer PAC services 24/7. 
Majority of the health facilities had intravenous fluids 
(93%), parenteral antibiotics (86%) and oxytocin (86%) 
while misoprostol (42%) was grossly lacking with MVA 
sets in only 70% of them. Approximately 74% of the 
health facilities had motorised transport for referral; 
and only 42% had a health provider accompanying the 
referral. A comparison of the central and eastern regions 
for PAC readiness revealed that the central region had 
significantly more MVA sets (p=0.003), motorised trans-
port for referral (p=0.004) and health provider accompa-
niment of referrals (p=0.034). Availability of uterotonics, 
intravenous fluids, parenteral antibiotics, communica-
tion means, blood transfusion services and surgical/lapa-




This study reveals the high burden of abortion- related 
morbidity and mortality in Uganda which agrees with 
evidence from similar settings with highly restrictive 
abortion laws.2 28 Close to 1.8% of women with SAM died 
particularly those in the second trimester. The Eastern 
region of the country had less PAC readiness, only 40% of 
facilities had MVA kits compared with 86% in the Central 
region (p=0.003) but also had worse abortion- related 
near- miss and mortality outcomes.
A WHO multicountry survey of 23 countries cites 
Uganda second to Afghanistan in reporting abortion- 
related severe maternal outcomes.2 Uganda has one of 
the highest fertility rates in the sub- Saharan region hence 
more pregnancy- related complications.29 We report a 
high ANMR of 938 per 100 000 live births, which can 
be attributed to the fact that we modified the near- miss 
definition to also include those with at least two instead 
of at least five blood transfusions.14 15 Despite the huge 
morbidity burden shown in this study, our AMR (23 per 
100 000 live births) is lower compared with other coun-
tries like Zambia (52 per 100 000 live births), and Nigeria 
(85 per 100 000 live births).10 14 15
PAC is globally accepted as life- saving care to women 
with abortion complications.30 In Uganda, PAC is 
recognised as a core signal function from health centre 
III level, and trained health providers including midwives 
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can manage bleeding complications by performing MVA 
especially for first trimester abortions. This deliberate 
effort by the Uganda Ministry of Health to task share in 
patient management probably contributes to the reduced 
mortality from abortion complications.19
Our study shows that ANM morbidity and mortality 
is greater in the Eastern region compared with the 









Abortion near- miss 
row %‡
(95% CI) χ P value§
Age group (years) 8.74 0.22
  <18 180 94 52 (37 to 67)
  18–24 1335 572 43 (29 to 58)
  25–29 729 334 46 (33 to 59)
  30–34 542 260 48 (36 to 60)
  35 + 529 247 47(29 to 65)
Number of pregnancies 9.75 0.22
  1 752 313 42(28 to 56)
  2 589 263 45(30 to 60)
  3 482 216 45(32 to 59)
  4 369 167 45(32 to 59)
  5 or more 1123 548 49(33 to 65)
Gestation age 13.66¶ 0.33¶
  First trimester 1459 589 40(23 to 61)
  Second trimester 1044 499 48(36 to 59)
  Trimester not indicated 812 419 52(36 to 67)
HIV status 10.18** 0.12**
  Negative 2388 942 39(26 to 55)
  Positive 148 78 53(37 to 68)
Not recorded 779 487 63(44 to 78)
Timing of complications 7.75 0.07
  At arrival or within 12
  hours
3253 1468 45(31 to 60)
  Developed after 12 hours 62 39 63(46 to 77)
Referral status 198.11 <0.001
  Not referred 2880 1173 41(28 to 55)
  Referred†† 435 334 77(64 to 86)
Type of health facility 34.22 0.42
  Health Centre 1204 628 52(34 to 70)
  Hospital 2111 879 42(25 to 61)
Ownership of health facility 18.7 0.40
  Public 2675 1265 47(31 to 64)
  Private 640 242 38 (25 to 53)
*Number of women with severe abortion complications in each row category, the denominator includes abortion near- miss cases as well .
†Number of abortion near- miss cases in each row category.
‡Proportion of women with abortion near- miss out of the total with severe abortion complications in each row category.
§Using the Pearson χ2 to test difference in the proportion of all severe abortion complications that are near- miss across different 
sociodemographic, reproductive and institutional characteristics.
¶Excludes patients where the trimester was not indicated.
**Excludes patients that did not have a recorded HIV status.
††Patients referred into the health facility for management of abortion complications.
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central region of the country. The Eastern region is 
characterised by a slightly younger age of sexual debut 
and higher unmet need for family planning which 
translates to increased unintended pregnancies.22 31 32 
Previous evidence shows that the Eastern region has a 
huge burden of unintended pregnancies, 8% of them 
end in abortions and complications occur in 58% of the 
women.22 Family planning or postabortion contraception 
is a key intervention to reduce unintended pregnan-
cies and repeat unsafe abortions respectively, ultimately 
decreasing ANM and mortality. In addition, access to 
safe abortion within the confines of the law mitigates the 
negative effects of unsafe abortion.
Our health facility assessment in the two regions reveals 
that the Eastern region has less readiness to manage abor-
tion complications such as fewer MVA kits—yet these are 





Proportion (%) of complication 
among severe abortion 
complications †
(95% CI) N=3315
Proportion (%) of 




Maternal deaths 37 1 (0 to 3) N/A
Infection 243 7 (4 to 12) 16 (10 to 24)
Organ dysfunction 1138 34 (23 to 48) 76 (65 to 84)
Management options
Types of uterine evacuation
  Spontaneous expulsion 1086 35 (24 to 47) 41 (27 to 56)
  Evacuation/MVA 2038 65 (53 to 75) 58 (43 to 72)
  Medical 17 1 (0 to 1) 1 (0 to 3)
Uterotonics administered
  Misoprostol 950 33 (23 to 46) 40 (27 to 54)
  Oxytocin 1826 64 (52 to 75) 58 (44 to 71)
  Other uterotonics 69 2 (1 to 11) 2 (1 to 7)
Additional interventions
Blood transfusion
  Yes 636 -§ 42 (24 to 62)
Blood units received (n=636)
  1 367¶ -§ 58 (45 to 69)**
  2 188 -§ 30 (23 to 37)**
  3–4 64 -§ 10 (5 to 18)**
  5 or more 10 -§ 2 (1 to 3)**
Units unknown 7 -§ 1 (0 to 3)**
Laparotomy(n=27)
  Done <3 hours from 
admission
9 -§ 33 (12 to 64)
  Done 3–12 hours from 
admission
14 -§ 52 (21 to 81)
  Performed after 12 hours of 
admission
4 -§ 15 (5 to 36)
Pearson χ2 was the statistical test used however we do not present the χ2 or p value .
*Number of all women with each row characteristic.
†Proportion of severe abortion complications with row characteristic out of the total number of severe abortion complications, severe 
abortion complications also include the near- miss cases.
‡Proportion of abortion near- miss cases with row characteristic out of the total number of abortion near- miss cases.
§All patients who received additional interventions (blood transfusion and laparotomy) were near- miss cases.
¶Women who received only one unit of blood transfusion but had other near- miss criteria.
**Proportion of women who received each number of blood transfusions out of 636.
MVA, manual vacuum aspiration.
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critical in removing uterine contents to control bleeding 
following an abortion. In the event of referral, facilities 
in the Eastern region are less likely to have motorised 
transport or a trained health provider accompany the 
referred woman to a higher health facility. Kananura et 
al report a profound lack of abortion services and MVA 
Table 4 Background indicators, complications and management options of abortion near- miss cases by pregnancy trimester
Characteristic
Abortion near- miss
Column % (95% CI)
Prevalence ratio*







27 (0.2) 26 (0.2) 0.99 (0.98 to 1.00) 0.17
Median no of pregnancies (IQR) 3 (2–6) 3 (2–5) 0.99 (0.97 to 1.01) 0.48
HIV status¶
  Negative 69 (56 to 79) 70 (56 to 82) Ref
  Positive 4 (3 to 8) 5 (3 to 9) 1.10 (0.83 to 1.45) 0.52
Timing of complications
  At arrival or within 12 hours 98 (96 to 99) 95 (92 to 97) Ref
  Developed after 12 hours 2 (1 to 4) 5 (3 to 8) 1.37 (1.07 to 1.76) 0.01
Referral status
  Not referred 82 (73 to 88) 79 (68 to 86) Ref
  Referred 18 (12 to 27) 21 (14 to 32) 1.11 (0.87 to 1.42) 0.40
Type of health facility
  Hospital 44 (24 to 66) 52 (28 to 75) Ref
  Health centre 56 (34 to 76) 48 (25 to 72) 0.85 (0.61 to 1.18) 0.32
Ownership of health facility
  Public 85 (69 to 94) 87 (84 to 90) Ref
  Private 15 (6 to 31) 13 (5 to 29) 0.92 (0.74 to 1.14) 0.44
Complications and outcome
Infection 15 (8 to 24) 17 (10 to 27) 1.08 (0.86 to 1.37) 0.49
Organ dysfunction 80 (68 to 88) 78 (68 to 86) 0.96 (0.80 to 1.16) 0.66
Management options
Types of uterine evacuation
  Spontaneous expulsion 37 (20 to 59) 53 (37 to 69) Ref
  Evacuation/MVA 62 (41 to 80) 45 (31 to 60) 0.69 (0.51 to 0.93) 0.02
  Medical 0 (0 to 2) 2 (0 to 7) 1.49 (0.96 to 2.30) 0.07
Uterotonics administered
  Misoprostol 40 (27 to 55) 43 (29 to 59) Ref
  Oxytocin 57 (43 to 70) 55 (39 to 70) 0.94 (0.78 to 1.15) 0.55
  Other uterotonics 3 (1 to 10) 2 (1 to 5) 0.86 (0.53 to 1.39) 0.53
Laparotomy(n=27)
  Done <3 hours from admission 25 (3 to 76) 33 (4 to 85) Ref
  Done 3–12 hours from admission 50 (9 to 91) 50 (10 to 90) 0.90 (0.25 to 3.23) 0.85
  Performed after 12 hours of 
admission
25 (3 to 76) 17 (3 to 60) 0.75 (0.12 to 4.85) 0.73
*These are unadjusted prevalence ratio estimates for generalised linear models with binomial family and loglink.
†P value of the prevalence ratio when the null hypothesis of no difference between ANM in first and second trimester for the characteristic is 
true as extracted from the generalised model.
‡Proportion of near- miss cases in the first trimester with row characteristic.
§Proportion of near- miss cases in the second trimester with row characteristic.
¶HIV status missing for 32% (487/1507) of the near- miss cases.
MVA, manual vacuum aspiration.
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sets in 40 health facilities, ranging from Health Centre 
IIIs to hospitals, from three districts in the same region.33 
Inability to obtain EmOC at nearby health facilities due to 
lack of supplies and commodities, non- accompaniment 
to the next referral site using non- motorised means on 
bad terrain road infrastructure increases complication 
rates or death due to delay in accessing appropriate crit-
ical care.33–35
SAM cases were 42% in first trimester and 31% in 
the second trimester; 2% of the women with SAM died 
in second trimester and 0.3% in the first trimester. The 
former could reflect the higher frequencies of preg-
nancies ending in the first trimester than in the second 
trimester; while the latter agrees with previous studies 
which show that mortality from abortion complications 
like bleeding and infection increases with gestation 
age.36–38 The Uganda national reproductive guidelines 
recommend use of surgical techniques, under general 
anaesthesia or heavy sedation by doctors for second 
trimester evacuations. It is worth noting that second 
trimester near- miss cases were less likely to have uterine 
evacuation compared with spontaneous expulsion. One 
possible explanation could be that second trimester abor-
tions tend to be spontaneous hence the complete expul-
sion. However, it might as well reflect a gap in accessing 
surgical services overall for abortion cases. Only 85% of 
comprehensive EmOC facilities had surgical/laparotomy 
capability, this may delay patients to receive appropriate 
surgical care further increasing the severity of the compli-
cations with some ending as maternal deaths.
ANM is increased among referrals, who can be identi-
fied as high risk cases that require close monitoring. Unlike 
other studies where majority of maternal near- misses develop 
either before or at admission,39 ANM mainly occurred 
after 12 hours of admission showing that the cascade of 
near- miss and mortality can be disrupted if the quality of 
care is improved and the health facility/providers respond 
promptly to women who are already in their care.
Despite blood transfusion being a core component of 
the near- miss classification particularly in a condition 
such as abortion where massive haemorrhage occurs, 
over 39% of transfused patients were discharged with an 
Hb less than 70 g/L denoting severe anaemia according 
to WHO recommendations.40 With only 64% of the 
comprehensive EmOC facilities able to offer blood trans-
fusion services, this study and others in similar settings 
demonstrate the scarcity of blood products in low and 
middle income countries.14 26 41 42 We did not perform a 
comparative analysis using the WHO near- miss definition 
of massive transfusion of 5 blood units due to the small 
number of 17 cases that got a massive transfusion. We 
had done some more analysis on the cut- off in another 
paper published from this database.27
Strengths and limitations
A strength of the study is a large data set of over 12 800 
women from the primary trial with severe maternal 
morbidity and mortality from 43 health facilities in 18 
districts of the country, from which eligible records of 
those with 3315 severe abortion complications were 
extracted, enhancing the generalisability of the results. 
We used the WHO maternal near- miss tool. We modi-
fied the data collection tool to include severe abortion 
complications,43 and amended the definition to include 
all those who received at least two units of blood trans-
fusion.26 41 42 We acknowledge that some researchers 
cite discrepancies in reporting using modified WHO 
near- miss tool, however, with a clear reporting of the 
Table 5 Health facility readiness for postabortion care (PAC) in 43 health facilities in central and eastern Uganda
Indicator










  Misoprostol 18 (41.9) 9 (32.1) 9 (60.0) 0.075
  Oxytocin 37 (86.1) 23 (82.1) 14 (93.3) 0.304
  Manual vacuum aspirators 30 (69.8) 24 (85.7) 6 (40.0) 0.003
  Intravenous fluids 40 (93.0) 25 (89.3) 15(100) 0.541
  Parenteral antibiotics 37 (86.1) 25 (89.3) 12 (80.0) 0.647
  Provision of PAC services 24/7 43 (100) 28 (100) 15 (100) –
  Motorised transport for referral 32 (74.4) 25 (89.3) 7 (46.7) 0.004
  Health provider accompanying referral 18 (41.9) 15 (53.6) 3 (20.0) 0.034
  Communication means 17 (39.5) 13 (46.4) 4 (26.7) 0.207
  Blood transfusion services† 25 (64.1) 19 (67.9) 6 (54.6) 0.297
  Surgical/laparotomy capability† 33 (84.6) 25 (89.3) 8 (72.7) 0.323
The indicators were measured for all 43 health facilities unless otherwise stated.
*χ2 or Fischer’s exact test done to compare PAC health facility readiness between the central and eastern regions.
†Only assessed for 39 health facilities that offer comprehensive emergency obstetric care services.
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methodology,44 we believe that comparison with other 
studies should be possible. It is the first study to give a 
detailed description of sociodemographic, reproductive 
characteristics, clinical presentation and management 
options for ANM cases by pregnancy trimester. The data 
collection process lasted a period of 15 months negating 
effects of variations by seasons unlike most abortion 
morbidity studies that take a shorter duration, hence 
more accurate estimates.
The study had some limitations. Data abstraction from 
patient files may miss some information due to incom-
plete clinical records, for example, gestation age and 
HIV status, as cited in other studies. Regular supervision 
visits were done to provide constant reminders to staff on 
complete documentation and perform verification with 
the clinical records and ward registers for the filled tools 
with subsequent inclusion of the missing information. 
The data were prospectively collected to reduce risk of 
missing data. We did not collect information on all abor-
tion cases admitted at these health facilities, so could not 
ascertain the total number of pregnancies that termi-
nated in the first and second trimesters, and whether 
the abortions were spontaneous or induced. However, 
it is worth noting that the recommended standard of 
reporting ANM is per live births.24
Interpretation
ANM and mortality evidence can be captured using the 
adapted WHO maternal near- miss criteria particularly 
in low- income settings. Women with second trimester 
abortion complications need urgent attention to avert 
severe abortion- related complications and deaths. Provi-
sion of essential drugs and supplies is crucial to averting 
abortion- related near- miss and deaths. We cannot infer 
causality as the prospective near- miss and the health 
facility data come from two different cross- sectional 
surveys. Still, our analysis indicates that the differences 
observed between the two settings underscore the impor-
tance of quality PAC services to address abortion- related 
mortality. Appropriately defined studies may further 
investigate into these associations.
CONCLUSION
We report an overall high ANMR and AMR, particularly in 
the Eastern region of the country; and a greater propor-
tion of abortion- related deaths in second trimester. 
However, mortality is lower compared with studies done 
in similar settings. ANM is more likely among referrals. 
The second trimester near- miss is more likely to occur 
after 12 hours of admission, and less likely to have surgical 
uterine evacuation. Only three- quarters of health facili-
ties in Uganda that provide comprehensive EmOC have 
functional blood transfusion services. This coupled with 
the moderate number of transfused patients at discharge 
still having severe anaemia shows that use of the adapted 
WHO near- miss criteria in low- income settings may be 
more applicable than the strict criteria.27 There’s a lack 
of key supplies and commodities, for example, MVA kits, 
parenteral antibiotics and uterotonics like misoprostol 
which impede access to appropriate care. Policy- makers 
should strengthen primary prevention strategies like 
family planning and harm reduction strategies to reduce 
the burden of unintended pregnancy and resulting abor-
tion complications. Life- saving drugs and supplies should 
be available in the health system and referral pathways 
strengthened to ensure patients access emergency appro-
priate care early. Finally, abortion maternal death and 
ANM audit should be implemented and arising recom-
mendations instituted to curtail the vicious cycle of abor-
tion morbidity and mortality.
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